Byrial Pernille, Clausen Loa, Nyboe Lene
Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Aarhus N, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark.
Physiother Res Int. 2023 Apr;28(2):e1980. doi: 10.1002/pri.1980. Epub 2022 Nov 9.
As motor impairments have implications for health and functioning, they need to be addressed early, not only in childhood but also in adolescence, the period in which mental disorders as schizophrenia, typically develops. Further, the possible prognostic value of motor impairments in schizophrenia highlights the importance. The Bruininks-Oseretsky Test of Motor Proficiency (BOT-2) and the Movement Assessment Battery for Children (MABC-2) assess adolescent motor performance. However, MABC-2 is not valid past age 16 and has no sex-norms. Further, while the concurrent validity between the tests and their ability to distinguish between clinical and non-clinical groups has been established in children, however they have not been established in adolescence.
To compare the ability of MABC-2 and BOT-2 to distinguish between adolescents with and without schizophrenia, to examine the concurrent validity between tests, to examine the agreement between tests in classifying adolescents "at risk" or scoring "below average" and to examine the influence of age and sex on MABC-2.
Motor performance assessed by BOT-2 and MABC-2 was compared in 25 adolescents with schizophrenia (14-18) and age- and sex-matched controls using t-test, Cohen's D and false discovery rate's q-value. The associations between tests were assessed using Pearson's correlation and Lin's concordance correlation coefficient. The Kappa coefficient was used to assess the agreement between tests in classifying "risk/below average" and linear regression was adopted to assess the influence of age/sex on MABC-2.
MABC-2 and BOT-2 significantly distinguished adolescents with schizophrenia from controls with large effect size. A strong association (p > 0.001) was found between the tests. The tests revealed moderate agreement in identifying "risk" or scoring "below average". Only sex influenced MABC-2 scores.
MABC-2 and BOT-2 are both useful for assessing motor performance and distinguishing between adolescents with and without schizophrenia, although BOT-2 provides a more detailed picture of the challenges in adolescent with schizophrenia.
由于运动障碍会影响健康和功能，因此需要尽早解决，不仅在儿童期，而且在青少年期，精神分裂症等精神障碍通常在这一时期发病。此外，运动障碍在精神分裂症中的可能预后价值凸显了其重要性。布鲁因inks - 奥塞雷茨基运动能力测试（BOT - 2）和儿童运动评估量表（MABC - 2）用于评估青少年的运动表现。然而，MABC - 2在16岁以后无效且没有性别常模。此外，虽然在儿童中已经确立了这些测试之间的同时效度以及它们区分临床组和非临床组的能力，但在青少年中尚未确立。
比较MABC - 2和BOT - 2区分有精神分裂症和无精神分裂症青少年的能力，检验测试之间的同时效度，检验测试在对“有风险”青少年进行分类或“低于平均水平”评分方面的一致性，并检验年龄和性别对MABC - 2的影响。
使用t检验、科恩d值和错误发现率的q值，比较25名患有精神分裂症的青少年（14 - 18岁）以及年龄和性别匹配的对照组通过BOT - 2和MABC - 2评估的运动表现。使用皮尔逊相关系数和林氏一致性相关系数评估测试之间的关联。kappa系数用于评估测试在分类“风险/低于平均水平”方面的一致性，采用线性回归评估年龄/性别对MABC - 2的影响。
MABC - 2和BOT - 2显著区分了患有精神分裂症的青少年和对照组，效应量较大。测试之间发现了很强的关联（p > 0.001）。测试在识别“风险”或评分“低于平均水平”方面显示出中等一致性。只有性别影响MABC - 2得分。
MABC - 2和BOT - 2都有助于评估运动表现并区分有精神分裂症和无精神分裂症的青少年，尽管BOT - 2能更详细地呈现患有精神分裂症青少年所面临的挑战。
